Perspectivas del mercado y visión del analista:
Los trastornos de hipopigmentación pueden convertirse en trastornos de despigmentación. Es una condición en la que los niveles de pigmento de la piel están por debajo del óptimo, a diferencia de las condiciones de despigmentación que ocurren debido a la eliminación completa de los pigmentos. Los principales factores que impulsan el crecimiento del mercado de tratamiento de los trastornos de hipopigmentación son la creciente conciencia relacionada con los trastornos de hipopigmentación, los avances tecnológicos en los tratamientos estéticos y el aumento continuo del envejecimiento de la población. Además, se prevé que la creciente incidencia de trastornos relacionados con la hipopigmentación, como el albinismo, la posthipopigmentación y el vitíligo, impulsen el mercado de tratamiento de los trastornos de hipopigmentación en los próximos años. Además, se prevé que el creciente gasto de los consumidores en la salud de la piel y la concienciación relacionada con el tratamiento beneficie a este mercado en un futuro próximo. Se espera que la introducción de componentes naturales y de origen vegetal genere tendencias en el mercado del tratamiento del trastorno de hipopigmentación en los próximos años, ya que estos productos han sido fundamentales para satisfacer la demanda mundial de productos cosmecéuticos hasta el momento. El costo de los tratamientos cosméticos y la cirugía, por otro lado, restringe el crecimiento del mercado.
Según el registro nacional de ensayos clínicos (NCT), en junio de 2020, Incyte Corporation llevó a cabo un ensayo clínico de fase II para Ruxolitinib para evaluar su seguridad y eficacia en el tratamiento del vitiligo en sujetos inscritos en los EE. UU. Por lo tanto, el creciente número de ensayos clínicos asociados con los trastornos de hipopigmentación es otro factor clave que impulsa el mercado.
Impulsores y desafíos del crecimiento:
La creciente prevalencia de los trastornos hipopigmentarios impulsa el crecimiento del mercado
>La pitiriasis alba, el vitíligo, el albinismo y la hipopigmentación posinflamatoria se encuentran entre las principales indicaciones de enfermedades asociadas con los trastornos de hipopigmentación. El vitíligo es una indicación de enfermedad común en todo el mundo. Según un estudio publicado en Dermatology Practical and Conceptual en diciembre de 2023, el vitíligo es una afección cutánea frecuente que afecta a ambos sexos. No obstante, es más frecuente en mujeres y más del 60 % de los pacientes experimentan la aparición de la enfermedad antes de los 30 años. Se prevé que el aumento de la incidencia y la prevalencia del vitiligo contribuyan aún más a la creciente demanda de tratamientos para la hipopigmentación.
Según un artículo publicado en Zagazig University Medical Journal en marzo de 2023, los trastornos de hipopigmentación son un grupo común de dermatosis en pediatría; La prevalencia de los trastornos de hipopigmentación varía de un país a otro, oscilando entre el 3,6% y el 9,9%. Además, la llegada y adopción de procedimientos mínimamente invasivos, un menor tiempo de ingreso hospitalario y menos dolor y menos complicaciones asociadas con los procedimientos han sido fundamentales para la creciente popularidad de los procedimientos mínimamente invasivos. Según la Sociedad Estadounidense de Cirujanos Plásticos (ASPS) en 2021, la cantidad de procedimientos cosméticos mínimamente invasivos realizados en los EE. UU. ha aumentado casi un 200% desde 2000. Por lo tanto, la creciente preferencia por los procedimientos cosméticos mínimamente invasivos impulsa aún más el tratamiento del trastorno de hipopigmentación. el crecimiento del mercado. Por otro lado, el coste de la fototerapia para indicaciones de enfermedades como el vitíligo y el albinismo es elevado. Además, los procedimientos quirúrgicos para tratar el vitíligo son muy caros. Por lo tanto, el alto costo de los tratamientos limita su adopción, lo que limita el crecimiento del mercado de tratamiento del trastorno de hipopigmentación.
Perspectivas estratégicas
Segmentación y alcance del informe:
El trastorno de hipopigmentación El análisis del mercado de tratamientos se ha llevado a cabo considerando los siguientes segmentos: tratamiento, indicación de enfermedad y usuario final. El alcance geográfico del informe de mercado de Tratamiento del trastorno de hipopigmentación incluye América del Norte (EE. UU., Canadá y México), Europa (Reino Unido, Alemania, Francia, Italia, España y resto de Europa), Asia Pacífico (China, Japón, India, Australia). , Corea del Sur y el resto de Asia Pacífico), Medio Oriente y África (EAU, Arabia Saudita, Sudáfrica y el resto de Medio Oriente y África) y América del Sur y Central (Brasil, Argentina y el resto de América del Sur y Central). América).
Análisis segmentario:
Información basada en el tratamiento
Según el tratamiento, el mercado se segmenta en medicamentos tópicos, terapia con láser, exfoliaciones químicas, microdermoabrasión, fototerapia, y otros. El segmento de medicamentos tópicos tuvo la mayor cuota de mercado de tratamiento del trastorno de hipopigmentación en 2023 y se prevé que registre la CAGR más alta durante 2023-2031.
Perspectivas basadas en indicaciones de enfermedades
Según la indicación de la enfermedad, el El mercado de tratamiento del trastorno de hipopigmentación se segmenta en pitiriasis alba, albinismo, vitíligo, hipopigmentación posinflamatoria y otros. El segmento de vitíligo tenía una participación de mercado significativa en 2023 y se espera que registre la CAGR más alta durante 2023-2031.
Información basada en el usuario final
En términos de usuario final, el mercado Se clasifica en clínicas de estética, centros de dermatología y hospitales. El segmento de clínicas de estética tuvo la mayor cuota de mercado de tratamiento del trastorno de hipopigmentación en 2023; Además, se prevé que registre la CAGR más alta del mercado durante 2023-2031.
Análisis regional:
América del Norte tuvo la mayor participación del mercado de tratamiento del trastorno de hipopigmentación en 2023, y es Se prevé que mantenga su dominio (en términos de participación) durante el período previsto. Estados Unidos domina el mercado en esta región (con la mayor participación) y en el mundo. Entre los factores notables que impulsan el crecimiento del mercado se encuentran una infraestructura sanitaria bien establecida, una mayor conciencia entre las personas sobre la salud de su piel, una creciente prevalencia de enfermedades asociadas con trastornos de hipopigmentación y una presencia significativa de empresas que ofrecen opciones de tratamiento atractivas para pacientes con hiperpigmentación posinflamatoria. en Norte América. Además, las preocupaciones por los crecientes estándares de belleza entre los asiáticos, un gran número de empresas que ingresan al mercado y el crecimiento continuo de actores establecidos se encuentran entre los factores clave que contribuyen a la expansión del tamaño del mercado de tratamiento del trastorno de hipopigmentación en Asia Pacífico. >
Panorama competitivo y empresas clave:
El pronóstico del mercado de Tratamiento del trastorno de hipopigmentación puede ayudar a las partes interesadas en este mercado a planificar sus estrategias de crecimiento. Allergan, SkinCeuticals, Pierre Fabre Group, Incyte Corporation, Episciences Inc., Phio Pharmaceuticals, Obagi Cosmeceuticals LLC, Alvogen, Bella Aurora, AbbVie son algunas de las empresas clave descritas en el informe de mercado del tratamiento del trastorno de hipopigmentación. Estas empresas se centran en ampliar su oferta de productos para satisfacer la creciente demanda de los consumidores en todo el mundo. Su presencia global les permite atender a muchos clientes.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Growing prevalence of skin diseases and rising demand for affordable and effective treatment solution globally. In 2023, the World Health Organization released estimates that skin diseases impacted over 1.8 million people worldwide. However, the stringent regulatory processes and high cost of hypopigmentation disorder treatment is expected to hinder the growth of the hypopigmentation disorder treatment market.
Hypopigmentation disorders are skin conditions caused due to loss in skin color. These disorders include vitiligo, albinism, and pityriasis alba among other disorders. Treatment depends on the severity of specific disease conditions.
The hypopigmentation disorder treatment market was valued at US$ 4,428.57 million in 2023.
The hypopigmentation disorder treatment market has major market players, including Allergan, SkinCeuticals, Pierre Fabre, EpiSciences, Incyte, STRATA Skin Sciences, AVITA Medical, Galderma S.A.
Based on type, the topical drugs segment in the hypopigmentation disorder treatment market is expected to record the fastest CAGR from 2023 to 2031. Factor such as ease of convenience of taking these drugs, increasing number of topical drugs to treat hypopigmentary scars.
The hypopigmentation disorder treatment market is expected to be valued at US$ 6,750.10 million in 2030.
Based on disease indication type, the hypopigmentation disorder treatment market is segmented into pityriasis alba, vitiligo, albinism, PIH and others. Vitiligo is anticipated to gain significant traction in the upcoming years. Rising prevalence of vitiligo globally and number of patients suffering from this disease is expected to drive the market growth.
The List of Companies - Hypopigmentation Disorder Treatment Market
- Allergan
- SkinCeuticals
- Pierre Fabre
- Obagi Cosmeceuticals LLC
- Incyte
- Galderma S.A.
- TeVido BioDevices, Inc.
- STRATA Skin Sciences
- AVITA Medical
- Courage + Khazaka electronic GmbH
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Mar 2024
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2024
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Mar 2024
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Mar 2024
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2024
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2024
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Mar 2024
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Mar 2024
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)